Skip to Content
Merck
CN

M10069

4-Methoxybenzamide

98%

Synonym(s):

p-Anisamide

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
CH3OC6H4CONH2
CAS Number:
Molecular Weight:
151.16
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
222-319-6
MDL number:
Assay:
98%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

98%

mp

164-167 °C (lit.)

SMILES string

COc1ccc(cc1)C(N)=O

InChI

1S/C8H9NO2/c1-11-7-4-2-6(3-5-7)8(9)10/h2-5H,1H3,(H2,9,10)

InChI key

GUCPYIYFQVTFSI-UHFFFAOYSA-N



Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Prashant Kesharwani et al.
Mini reviews in medicinal chemistry, 17(18), 1725-1745 (2016-02-20)
Nanoparticles (NPs), the submicron-sized colloidal particles, have recently generated enormous interest among biomedical scientists, particularly in cancer therapy. A number of models are being used for exploring NPs safety and efficacy. Recently, cancer cell lines have explored as prominent experimental
Chong Su et al.
Advanced drug delivery reviews, 143, 97-114 (2019-07-01)
Nanocarriers (NCs) are a type of drug delivery system commonly used to regulate the pharmacokinetic and pharmacodynamic properties of drugs. Although a wide variety of NCs has been developed, relatively few have been registered for clinical trials and even fewer
Andrew B Satterlee et al.
Theranostics, 7(2), 253-269 (2017-01-04)
Aggressive, desmoplastic tumors are notoriously difficult to treat because of their extensive stroma, high interstitial pressure, and resistant tumor microenvironment. We have developed a combination therapy that can significantly slow the growth of large, stroma-rich tumors by causing massive apoptosis



Global Trade Item Number

SKUGTIN
M10069-5G04061831817584